APA (7th ed.) Citation

HOFFMANN, S., CEPOK, S., HEMMER, B., GRUMMEL, V., LEHMANN-HORN, K., HACKERMUELLER, J., . . . WASMUTH, R. (2008). HLA-DRB10401 and HLA-DRB10408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis. American journal of human genetics, 83(2), 219-227. https://doi.org/10.1016/j.ajhg.2008.07.006

Chicago Style (17th ed.) Citation

HOFFMANN, Steve, et al. "HLA-DRB10401 and HLA-DRB10408 Are Strongly Associated with the Development of Antibodies Against Interferon-β Therapy in Multiple Sclerosis." American Journal of Human Genetics 83, no. 2 (2008): 219-227. https://doi.org/10.1016/j.ajhg.2008.07.006.

MLA (9th ed.) Citation

HOFFMANN, Steve, et al. "HLA-DRB10401 and HLA-DRB10408 Are Strongly Associated with the Development of Antibodies Against Interferon-β Therapy in Multiple Sclerosis." American Journal of Human Genetics, vol. 83, no. 2, 2008, pp. 219-227, https://doi.org/10.1016/j.ajhg.2008.07.006.